BioMarin Pharmaceuticals Inc.

Claim Deadline: October 30, 2023

Settlement Fund: $39,000,000

Settlement Class

All persons and entities who purchased or otherwise acquired BioMarin common stock during the period from March 3, 2020 through August 18, 2020, inclusive.

Important Documents

Settlement Status

Preliminarily Approved

Class Period

March 03, 2020 - August 18, 2020

Settlement Hearing Date

November 08, 2023

Opt-Out Deadline

October 18, 2023

Claims Admin

A.B. Data, Ltd.
BioMarin Securities Litigation
c/o A.B. Data, Ltd.
P.O. Box 170400
Milwaukee,  WI   53217

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.